Arvinas has managed to secure another big pharma collaboration, after it announced that Pfizer had signed a research and licensing agreement. The deal adds to previous agreements signed with MSD and Genentech, cementing...

Biogen Inc struck a $1 billion neurology drug development deal with Ionis Pharmaceuticals on Friday, expanding a partnership that developed the company’s potential blockbuster drug for spinal muscular atrophy.

Novo Nordisk today announced an increased commitment to stem cell-based therapies and an expansion of the focus on type 1 diabetes into other serious chronic diseases. This has been made possible through an exclusive...

Novartis’ Sandoz unit had already staked a claim to being one of the leaders in the developing biosimilar market and has made another move to further expand its influence.
 

The FDA has announced its approval of a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), both products from Bristol Myers Squibb, for the treatment of previously untreated advanced renal cell carcinoma which...

Wat brengt 2018? Lees & noteer, zodat jij straks de know-it-all held van het kantoor bent.